These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6288301)

  • 1. Case report: management of methotrexate toxicity in an anephric patient.
    Langleben A; Hollomby D; Hand R
    Clin Invest Med; 1982; 5(2-3):129-32. PubMed ID: 6288301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature.
    Cossaart N; SantaCruz KS; Preston D; Johnson P; Skikne BS
    Bone Marrow Transplant; 2003 Jan; 31(1):57-60. PubMed ID: 12621508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy: case report and review of the literature.
    Perez-Verdia A; Angulo F; Hardwicke FL; Nugent KM
    Pharmacotherapy; 2005 Sep; 25(9):1271-6. PubMed ID: 16164401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
    Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
    Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.
    Glass A; Wieand HS; Fisher B; Redmond C; Lerner H; Wolter J; Shibata H; Plotkin D; Foster R; Margolese R; Wolmark N
    Cancer Treat Rep; 1981; 65(5-6):363-76. PubMed ID: 7016322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurologic and cardiac toxicity following iv application of methotrexate.
    Gasser AB; Tièche M; Brunner KW
    Cancer Treat Rep; 1982 Jul; 66(7):1561-2. PubMed ID: 7093971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute leukemia after adjuvant chemotherapy for breast cancer.
    Gabrail NY
    Mo Med; 1989 Oct; 86(10):689-90. PubMed ID: 2552279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of seven patients with occult breast cancer and literature reviews].
    Yu H; Yang MT; Rong TH; Long H; Ou W
    Ai Zheng; 2002 May; 21(5):541-3. PubMed ID: 12452050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes.
    Battelli N; Massacesi C; Braconi C; Pilone A; Manzione L; Dinota A; Cobelli S; Scanni A; Sturba F; Giacomini G; Morale D; Giorgi F; Tummarello D; Cascinu S
    Am J Clin Oncol; 2006 Aug; 29(4):380-4. PubMed ID: 16891866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast cancer during pregnancy--a case report].
    Matsunoki A; Yoshino H; Takayanagi T; Kadoya S; Kotake M; Ishiguro K; Kurokawa M; Morita K; Bandou H; Yamada C; Yamada T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):991-3. PubMed ID: 18633231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
    Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
    Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer in young women: case report and a review.
    Batori M; Ruggieri M; Chatelou E; Straniero A; Mariotta G; Palombi L; Casella G; Basile M; Casella MC
    Eur Rev Med Pharmacol Sci; 2006; 10(2):51-2. PubMed ID: 16705948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemoid reaction after methotrexate-induced pancytopenia in a patient undergoing continuous ambulatory peritoneal dialysis.
    Sun CY; Lin HC; Chen YC; Tsai CR; Wu MS
    Chang Gung Med J; 2006; 29(5):513-7. PubMed ID: 17214397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.